Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Van Scoyk

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Plos One|November 9, 2013
Heterotrimeric G-protein, Gα16, is a critical downstream effector of non-canonical Wnt signaling and a potent inhibitor of transformed cell growth in non small cell lung cancerSreedevi Avasarala, Rama Kamesh Bikkavilli, Michelle Van Scoyk, et al.
Neoplasia (New York, N.Y.)|March 18, 2010
Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1Meredith A Tennis, Michelle Van Scoyk, Lynn E Heasley, et al.
Biology Open|July 18, 2013
hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expressionSreedevi Avasarala, Michelle Van Scoyk, Jianbin Wang, et al.
The Journal of Biological Chemistry|May 1, 2015
Novel Role for γ-Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1)Marybeth Sechler, Stanley Borowicz, Michelle Van Scoyk, et al.
Molecular Cancer Research : MCR|October 18, 2019
PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated MacrophagesSreedevi Avasarala, Pei-Ying Wu, Samia Q Khan, et al.
The Journal of Biological Chemistry|April 8, 2015
PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung CancerSreedevi Avasarala, Michelle Van Scoyk, Manoj Kumar Karuppusamy Rathinam, et al.
The Journal of Biological Chemistry|February 12, 2005
Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiationRobert A Winn, Lindsay Marek, Sun-Young Han, et al.
The Journal of Biological Chemistry|March 10, 2017
K-homology splicing regulatory protein (KSRP) promotes post-transcriptional destabilization of Spry4 transcripts in non-small cell lung cancerRama Kamesh Bikkavilli, Sereke Adam Zerayesus, Michelle Van Scoyk, et al.
Cancer Letters|December 20, 2022
Miz1 promotes KRAS-driven lung tumorigenesis by repressing the protocadherin Pcdh10Jing Yang, Changchun Hou, Huashan Wang, et al.
Iscience|February 2, 2024
Cooperation between PRMT1 and PRMT6 drives lung cancer health disparities among Black/African American menPei-Ying Wu, Michelle Van Scoyk, Stephanie S McHale, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Plos One|November 9, 2013
Heterotrimeric G-protein, Gα16, is a critical downstream effector of non-canonical Wnt signaling and a potent inhibitor of transformed cell growth in non small cell lung cancerSreedevi Avasarala, Rama Kamesh Bikkavilli, Michelle Van Scoyk, et al.
Neoplasia (New York, N.Y.)|March 18, 2010
Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1Meredith A Tennis, Michelle Van Scoyk, Lynn E Heasley, et al.
Biology Open|July 18, 2013
hsa-miR29b, a critical downstream target of non-canonical Wnt signaling, plays an anti-proliferative role in non-small cell lung cancer cells via targeting MDM2 expressionSreedevi Avasarala, Michelle Van Scoyk, Jianbin Wang, et al.
The Journal of Biological Chemistry|May 1, 2015
Novel Role for γ-Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1)Marybeth Sechler, Stanley Borowicz, Michelle Van Scoyk, et al.
Molecular Cancer Research : MCR|October 18, 2019
PRMT6 Promotes Lung Tumor Progression via the Alternate Activation of Tumor-Associated MacrophagesSreedevi Avasarala, Pei-Ying Wu, Samia Q Khan, et al.
The Journal of Biological Chemistry|April 8, 2015
PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung CancerSreedevi Avasarala, Michelle Van Scoyk, Manoj Kumar Karuppusamy Rathinam, et al.
The Journal of Biological Chemistry|February 12, 2005
Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiationRobert A Winn, Lindsay Marek, Sun-Young Han, et al.
The Journal of Biological Chemistry|March 10, 2017
K-homology splicing regulatory protein (KSRP) promotes post-transcriptional destabilization of Spry4 transcripts in non-small cell lung cancerRama Kamesh Bikkavilli, Sereke Adam Zerayesus, Michelle Van Scoyk, et al.
Cancer Letters|December 20, 2022
Miz1 promotes KRAS-driven lung tumorigenesis by repressing the protocadherin Pcdh10Jing Yang, Changchun Hou, Huashan Wang, et al.
Iscience|February 2, 2024
Cooperation between PRMT1 and PRMT6 drives lung cancer health disparities among Black/African American menPei-Ying Wu, Michelle Van Scoyk, Stephanie S McHale, et al.
Pageof 2